A postmenopausal woman has metastatic breast cancer that is estrogen receptor negative. She is scheduled to begin chemotherapy the following week and asks her primary care NP what other medications her oncologist may prescribe to treat her cancer.
The NP should expect the oncologist to prescribe: a. toremifene (Fareston).
b. tamoxifen (Nolvadex).
c. fulvestrant (Faslodex).
d. anastrozole (Arimidex).
Question 2
Early-stage Alzheimer's disease is diagnosed in a patient, and the primary care NP recommends therapy with a ChE inhibitor. The patient asks why drug treatment is necessary because most functioning is intact.
The NP should explain that medication may: a. delay progression of symptoms.
b. produce temporary disease remission.
c. prevent depressive effects of the disease.
d. reduce the need for adjunct medications later on.